Immunitybio

Yahoo Finance • 3 days ago

Why ImmunityBio Inc. (IBRX) Went Up Last Week?

We recently published a list of 10 Stocks Outperform Broader Market Last Week. In this article, we are going to take a look at where ImmunityBio Inc. (NASDAQ:IBRX) stands against other stocks that outperformed broader market last week. Wa... Full story

Yahoo Finance • 8 days ago

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and ImmunityBio: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors

SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential violations of federal and state laws by certain officers of the following companies: Wolfspeed, Inc. (NYSE: WOLF), Driven Brands Holdings Inc.... Full story

Yahoo Finance • 18 days ago

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and ImmunityBio: Johnson Fistel, LLP Investigates Claims on Behalf of Investors

SAN DIEGO, March 14, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating potential violations of federal and state laws by certain officers of the following companies: Wolfspeed, Inc. (NYSE: WOLF), Driven Brands Holdings Inc. (... Full story

Yahoo Finance • last month

IMMUNITYBIO ALERT: Bragar Eagel & Squire, P.C. is Investigating ImmunityBio, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK , Feb. 27, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against ImmunityBio, Inc. (NASDAQ: IBRX) on behalf of long-term stockholders... Full story

Yahoo Finance • 2 months ago

Why ImmunityBio, Inc. (IBRX) Is Skyrocketing

We recently compiled a list of the 10 Firms Shine Amid Wall Street's Lackluster Trading.In this article, we are going to take a look at where ImmunityBio, Inc. (NASDAQ:IBRX) stands against the other stocks. A lackluster trading persisted... Full story

Yahoo Finance • 8 months ago

Chief Scientific Officer Patrick Soon-Shiong, ImmunityBio, Inc.'s (NASDAQ:IBRX) largest shareholder sees value of holdings go down 6.5% after recent drop

Key Insights Insiders appear to have a vested interest in ImmunityBio's growth, as seen by their sizeable ownership A total of 2 investors have a majority stake in the company with 62% ownership 10% of ImmunityBio is held by Institutions... Full story

Yahoo Finance • 10 months ago

ImmunityBio Announces 2024 Annual Meeting of Stockholders with Company Update

CULVER CITY, Calif., June 07, 2024--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX) announced today that its 2024 Annual Meeting of Stockholders will be held on Tuesday, June 11, 2024 at 9:30 a.m. Pacific Time. The Annual Meeting will be... Full story

Yahoo Finance • last year

ImmunityBio Quality-of-Life Study in BCG-Unresponsive Bladder Cancer Trial Indicates Improved Physical Function in the 71% Complete Responders Suggesting a Favorable Risk-Benefit Ratio for N-803 Plus BCG

Patient Reported Outcomes (PROs) based on a May 16, 2022 data cutoff in the QUILT 3.032 trial indicate stability of physical function and global health in patients who completed PRO questionnaires and reached month 24 on-study Overall, par... Full story

Yahoo Finance • last year

ImmunityBio Announces Biological License Application Resubmission for N-803 in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer Carcinoma-In-Situ

Provides updated data on prolonged duration of complete response in BCG-Unresponsive and BCG-Naïve NMIBC patients Following the Type A Meeting with the FDA, ImmunityBio has completed the BLA resubmission addressing the issues in the Compl... Full story

Yahoo Finance • last year

Lawsuit Notice: Investors who lost money with ImmunityBio, Inc. (NASDAQ: IBRX) shares should contact the Shareholders Foundation

SAN DIEGO, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of ImmunityBio, Inc. (NASDAQ: IBRX). Investors, who purchased ImmunityBio, Inc. (NASDAQ:... Full story

Yahoo Finance • 2 years ago

Lifshitz Law PLLC Announces Investigations of ImmunityBio, Inc. (NASDAQ: IBRX), BioXcel Therapeutics, Inc. (NASDAQ: BTAI), Baxter International Inc. (NYSE: BAX)

NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) -- ImmunityBio, Inc. (NASDAQ: IBRX) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that th... Full story

Yahoo Finance • 2 years ago

Investigation Alert BAX, DHR, BTAI, and IBRX: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below

SAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Baxter International, Inc. (NYSE: BAX) Johnson Fistel, LLP is investigating potential claims on behalf of Baxter International, Inc. (NYSE: BAX). If you are a current, long-term shareholde... Full story

Yahoo Finance • 2 years ago

Lifshitz Law PLLC Announces Investigations of Arrow Financial Corp. (NASDAQ: AROW), ImmunityBio, Inc. (NASDAQ: IBRX), BioXcel Therapeutics, Inc. (NASDAQ: BTAI), and Baxter International Inc. (NYSE: BAX)

NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) -- Arrow Financial Corp. (NASDAQ: AROW) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations tha... Full story

Yahoo Finance • 2 years ago

IBRX FINAL DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys Before Aug. 29th Deadline in Securities Fraud Class Action

SAN FRANCISCO, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022 – May 10, 2023 Lead Plaintiff Deadlin... Full story

Yahoo Finance • 2 years ago

SHAREHOLDER ALERT: Levi & Korsinsky Notifies ImmunityBio, Inc. (IBRX) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ImmunityBio, Inc. ("ImmunityBio" or the "Company") (NASDAQ: IBRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recov... Full story

Yahoo Finance • 2 years ago

DEADLINE ALERT for IBRX, BTAI, MNK, and STX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the... Full story

Yahoo Finance • 2 years ago

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ImmunityBio, Inc. of Class Action Lawsuit and Upcoming Deadline – IBRX

NEW YORK, Aug. 26, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX), and certain officers.   The class action, filed in... Full story

Yahoo Finance • 2 years ago

IBRX IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors with Losses to Secure Counsel Before Important August 29 Deadline in Securities Class Action – IBRX

NEW YORK, Aug. 25, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between May 23, 2022 and May 10, 2023, both dates inclusive (the “Cl... Full story

Yahoo Finance • 2 years ago

DEADLINE ALERT for IBRX, BTAI, MNK, STX, BAX: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

BENSALEM Pa. , Aug. 24, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story

Yahoo Finance • 2 years ago

IBRX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 29, 2023 in the Class Action Filed on Behalf of ImmunityBio, Inc. Shareholders

NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ImmunityBio, Inc. (NASDAQ: IBRX) alleging that the Company violated federal securities law... Full story